Pontus Andell (Former)
1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality
(
- Contribution to journal › Article
-
Mark
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)
(
- Contribution to journal › Article
-
Mark
Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder
(
- Contribution to journal › Article
- 2021
-
Mark
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
(
- Contribution to journal › Article
- 2020
-
Mark
Neighborhood socioeconomic status and aortic stenosis : A Swedish study based on nationwide registries and an echocardiographic screening cohort
(
- Contribution to journal › Article
-
Mark
Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction
(
- Contribution to journal › Article
-
Mark
Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings : A Nationwide Study
(
- Contribution to journal › Article
-
Mark
Time Trends in the Use of Coronary Procedures, Guideline-Based Therapy, and All-Cause Mortality following the Acute Coronary Syndrome in Patients with Schizophrenia
(
- Contribution to journal › Article
-
Mark
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
(
- Contribution to journal › Article
- 2019
-
Mark
Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial
(
- Contribution to journal › Article